Find stats on top websites
Major Markets
Promaxo positions itself as a revolutionary MedTech leader, bringing advanced, portable MRI technology directly into urology offices. They offer unparalleled precision in prostate cancer diagnosis and treatment, emphasizing improved outcomes and patient peace of mind through accessible, in-office care.
Customer sentiment appears to be positive, driven by the convenience, improved accuracy, and patient-centric approach of in-office MRI-guided procedures. Physicians likely appreciate the streamlined workflow and enhanced diagnostic confidence, while patients value the comfort and personalized care.
Promaxo's core value proposition is enabling precise, in-office MRI-guided prostate cancer diagnosis and treatment, significantly improving detection rates and patient outcomes. Their compact, easy-to-integrate system offers urologists enhanced diagnostic confidence and efficiency, providing patients with convenient, cutting-edge care.
Compact, portable MRI for office use, reducing barriers to adoption.
Superior clinical outcomes in prostate cancer detection.
Focus on customer-centric solutions and integrated workflow.
Robot is not yet commercially available, limiting current advanced features.
Lack of explicit subscription pricing information in provided context.
Reliance on a single product type (MRI for prostate cancer).
Expand into other interventional imaging applications beyond prostate cancer.
Leverage AI and robotics (once available) for enhanced capabilities.
Global market expansion, as suggested by international physician testimony.
Competition from established medical device manufacturers.
Regulatory hurdles for new medical device approvals and widespread adoption.
Rapid technological advancements potentially outpacing their current offerings.
The primary market is the US, with some reach in Canada and emerging interest in Brazil and parts of Europe, highlighting a focus on developed healthcare markets.
United States
85% market share
Canada
5% market share
Brazil
3% market share
United Kingdom
2% market share
Germany
1% market share
35-65 years
Male
USA • Canada • Europe • Brazil
50-75 years
Male
USA • Canada • Europe
30-55 years
Male • Female
USA • Europe • Asia
50-80 years
Male • Female
USA • Canada • Europe
30-60 years
Male • Female
USA • Global
Data shown in percentage (%) of usage across platforms
Develop an interactive ROI calculator on the Promaxo website. This will allow potential physician buyers to input their specific clinic data and see the potential return on investment from adopting the Promaxo MRI System, quantifying the benefits of improved diagnostic confidence and increased revenue.
Learn moreIntroduce a product satisfaction or performance guarantee for the Promaxo MRI System. This will reduce perceived risk for potential buyers by assuring them of the system's efficacy and reliability, increasing their confidence in making a purchase decision.
Learn moreEncourage urologists and patients to share their positive experiences with the Promaxo MRI System through testimonials, case studies, and video reviews. Featuring this user-generated content on the website and in marketing materials will build trust and credibility by showcasing real-world results and patient satisfaction.
Learn moreSign up now and unleash the power of AI for your business growth